Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery

A Before/After Study of the Impact of Quantitative Neuromuscular Monitoring and Sugammadex Reversal Following Gastric Bypass Surgery

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.

Inclusion Criteria:

• age greater than 18 years
• scheduled for an elective laparoscopic gastric bypass procedure

Exclusion Criteria:

• age less than 18 years
• pregnancy
• prisoners
• significant co-existing lung disease including asthma or chronic obstructive pulmonary disease (COPD) requiring regular medication
• patients who require supplemental oxygen pre-operatively to maintain a hemoglobin saturation (SpO2>98%)